Table 3 Clinical data for the outliner patient belonging to the low serum total IgE (sIgEtot) subgroup (see Fig. 1b)
From: Variability in total serum IgE over 1 year in severe asthmatics
Visit | Baseline | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|---|
sIgEtot (IU/mL) | 61.3 | 41 | 43 | 818 | 1159 | 357 | 266 |
FEV1 predicted (%) | 49 | 61 | 64 | 52 | 59 | 65 | |
Total ACQ score | 13 | 19 | 14 | 25 | 19 | 15 | 16 |
FENO (ppm) | 7.1 | 4.8 | 18.6 | 28.1 | |||
Asthma exacerbation | x | x | x | x | x | ||
Asthma exacerbation requiring OCS (if yes dosis mg) | 32 | 16 | |||||
Parasitic infection | x | ||||||
Budesonide/formoterol (µg/days) | 1200/54 | 1200/54 | 800/36 | 1200/54 | 1200/54 | 1200/54 | 1200/54 |
OCS dosis (mg/days) | 16 | 16 | 8 | 16 | 16 | 16 | 16 |
Beclamethasone/formoterol | 200/18 | 200/18 | 200/18 | 200/18 | |||
Salbutamol | x | x | x | ||||
Fenoterol/ipratropium | x | ||||||
Theophylline | x | x | x | x | x | ||
Azythromycine | x | x | x |